Your browser doesn't support javascript.
loading
Genetics of substance use disorders in the era of big data.
Gelernter, Joel; Polimanti, Renato.
Afiliação
  • Gelernter J; Department of Psychiatry, Yale University School of Medicine, West Haven, CT, USA. joel.gelernter@yale.edu.
  • Polimanti R; Department of Psychiatry, Veterans Affairs Connecticut Healthcare Center, West Haven, CT, USA. joel.gelernter@yale.edu.
Nat Rev Genet ; 22(11): 712-729, 2021 11.
Article em En | MEDLINE | ID: mdl-34211176
Substance use disorders (SUDs) are conditions in which the use of legal or illegal substances, such as nicotine, alcohol or opioids, results in clinical and functional impairment. SUDs and, more generally, substance use are genetically complex traits that are enormously costly on an individual and societal basis. The past few years have seen remarkable progress in our understanding of the genetics, and therefore the biology, of substance use and abuse. Various studies - including of well-defined phenotypes in deeply phenotyped samples, as well as broadly defined phenotypes in meta-analysis and biobank samples - have revealed multiple risk loci for these common traits. A key emerging insight from this work establishes a biological and genetic distinction between quantity and/or frequency measures of substance use (which may involve low levels of use without dependence), versus symptoms related to physical dependence.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Relacionados ao Uso de Substâncias / Estudo de Associação Genômica Ampla Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Relacionados ao Uso de Substâncias / Estudo de Associação Genômica Ampla Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article